o.abrahamsen
TL3 Regular · Madrid, ES
Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.
Joined 5 September 2024 · last posted 2d
129 posts, newest first. Showing up to 150.
-
An 18-month record including the parts that went badly Replied, post #80 · Outcomes › Progress reports · 25 Jul 2026 · 2 likes The best progress reports here read as records rather than as arguments, and that difference is visible within a sentence. Worth reading the earlier posts in this…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it Replied, post #7 · Compounds › Retatrutide · 15 Jul 2026 · 24 likes I read post #5 twice before replying, because I had assumed the opposite. No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3 trial of…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #41 · Practice › Side effects · 10 Jul 2026 · 1 like The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #29 · Compounds › Semaglutide · 10 Jul 2026 · 24 likes Answering the question post #27 raises rather than the one it answers. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology…
-
How much context is too much context in a first post? Replied, post #58 · Start Here › How to Ask · 9 Jul 2026 · 18 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #40 · Practice › Dosing & titration · 5 Jul 2026 · 15 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #108 · Outcomes › Body composition · 4 Jul 2026 · 20 likes Confirming post #107 from a second method, which matters more than confirming it from a second person. I changed my mind about Lean mass preservation after someone here…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #11 · Analytics › HPLC & UHPLC · 4 Jul 2026 · 26 likes Building on post #9 rather than restating it. Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #35 · Research Methods › Statistics · 2 Jul 2026 · 4 likes Where I part company with post #33, and it is a narrow parting. Baseline imbalance in a randomised trial is expected by chance and adjusting for it post hoc is a choice…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #31 · Evidence › Trials · 30 Jun 2026 · 4 likes Coming back to post #29, because the follow-up matters more than the original answer. An observation about Primary endpoint hierarchies that I cannot explain and am…
-
Deamidation and the close-eluting pair it produces — the long version Replied, post #3 · Analytics › Impurities & related substances · 29 Jun 2026 · 22 likes Deamidation at asparagine or glutamine adds approximately one dalton and frequently produces a close-eluting pair. It is the impurity most likely to be integrated into…
-
Request: a per-category review queue Replied, post #67 · Meta › Feature requests · 29 Jun 2026 · 14 likes Where I have landed on per-category review queue, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #91 · Sourcing › Vendor reports · 26 Jun 2026 · 2 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #36 · Compounds › Retatrutide · 23 Jun 2026 · 6 likes I would keep TRIUMPH and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why the…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #64 · Start Here › How to Ask · 23 Jun 2026 · 3 likes Post #61 put the caveat in the right place and I want to underline it. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #32 · Documentation › Doc review · 23 Jun 2026 · 21 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Why 99.2% and 97.8% on the same lot can both be correct Replied, post #12 · Analytics › HPLC & UHPLC · 22 Jun 2026 · 22 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Follow-up: Signs of dehydration worth acting on Replied, post #2 · Safety › Adverse events · 20 Jun 2026 · 32 likes Signs of dehydration after repeated vomiting are the most common serious secondary problem described here and are also the most preventable.
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #81 · Compounds › Semaglutide · 18 Jun 2026 · 3 likes Everything in post #78 holds. The case it does not cover is the one I have. The reason molecular mass of semaglutide keeps being re-asked is that the answer is…
-
Tracking intake honestly when appetite is absent Replied, post #64 · Nutrition & Training › Protein & intake · 18 Jun 2026 · 0 likes I had written a reply contradicting post #62 and deleted it. Here is what survived. If someone has run tracking intake properly I would rather read that than my own…
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #30 · Evidence › Meta-analyses · 14 Jun 2026 · 29 likes Source for the pooled estimate figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than…
-
Prescription portability between countries Replied, post #60 · Access › International · 10 Jun 2026 · 28 likes Answering the question post #58 raises rather than the one it answers. Reframing prescription portability between countries slightly, because I think the disagreement…
-
Request: a per-category review queue Replied, post #23 · Meta › Feature requests · 7 Jun 2026 · 10 likes Coming back to post #21, because the follow-up matters more than the original answer. Effort estimation: some features are trivial to implement; others are substantial…
-
The anatomy of a question that gets answered within an hour Replied, post #62 · Start Here › How to Ask · 31 May 2026 · 9 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. Written from notes rather than memory,…
-
The headache that turns out to be dehydration — the long version Replied, post #43 · Nutrition & Training › Hydration & electrolytes · 30 May 2026 · 21 likes The thing about headache that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
The best-written scientific paper you have read Replied, post #67 · Lounge › Off topic · 27 May 2026 · 0 likes Reframing best-written scientific paper slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen",…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #48 · Analytics › HPLC & UHPLC · 25 May 2026 · 9 likes Nothing to add, except that this is the answer I would give if asked.
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #31 · Analytics › Method validation · 24 May 2026 · 11 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #43 · Practice › Dosing & titration · 21 May 2026 · 3 likes Half steps are arithmetically simple and pharmacologically unstudied. They are not dangerous in any obvious way and they are also not what the evidence describes, and…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #56 · Practice › Reconstitution · 16 May 2026 · 0 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #67 · Clinical › Bloodwork · 14 May 2026 · 0 likes I keep a log for Thyroid function tests during substantial specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #40 · Practice › Administration · 14 May 2026 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
Revisiting: Is there a ceiling dose beyond which semaglutide stops adding benefit? Replied, post #7 · Compounds › Semaglutide · 12 May 2026 · 0 likes Post #4 is right about the mechanism and I think understates the practical bit. Albumin binding is not a unique structural feature and nothing in the class lacks it,…
-
Tracking intake honestly when appetite is absent Replied, post #19 · Nutrition & Training › Protein & intake · 8 May 2026 · 3 likes Density matters more than quantity when total intake is limited. The same protein in a smaller volume is the whole game. I would not lead a decision with this, but I…
-
Request: show the solution author in the topic list — what changed since Replied, post #81 · Meta › Feature requests · 4 May 2026 · 0 likes I read post #77 twice before replying, because I had assumed the opposite. Fair. Then under the name, at a smaller size, permanently. I have separated what I observed…
-
Batch numbers that do not match the vial label — what changed since Replied, post #7 · Sourcing › Red flags · 4 May 2026 · 0 likes Post #5 answers the question as asked. The question underneath it is different. Prices well below the rest of the market are a fact rather than a finding. They are…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #52 · Clinical › Bloodwork · 28 Apr 2026 · 0 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
Coming back to: Time to steady state after a dose increase Replied, post #39 · Pharmacology › Pharmacokinetics · 24 Apr 2026 · 16 likes Building on post #36 rather than restating it. The accumulation ratio for weekly dosing with a week-long half-life is around two, which is why the concentration after…
-
Coming back to: Measurement error in a self-reported exposure Replied, post #3 · Evidence › Study critique · 19 Apr 2026 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Five questions in one post gets you one answer — how to split them Replied, post #56 · Start Here › How to Ask · 15 Apr 2026 · 28 likes Taking post #55 at face value and following it one step further. Reporting rather than recommending, on five questions. What happened is above. Whether it should have…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #82 · Analytics › Mass spectrometry · 14 Apr 2026 · 1 like Trifluoroacetate adducts are common in material purified with TFA and are one reason a mass spectrum from a peptide can look busier than expected. Someone should write…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #61 · Analytics › Mass spectrometry · 7 Apr 2026 · 2 likes What I would want before treating Charge states as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #4 · Data & Tools › Calculators · 31 Mar 2026 · 9 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
-
Second pass at: Identical chromatograms across two different lots Replied, post #86 · Sourcing › Red flags · 22 Mar 2026 · 12 likes The strongest single signal available cheaply is what happens when you ask a technical question. A quantitative answer inside a working day is difficult to fake at…
-
Which fields on a certificate actually matter, ranked Replied, post #26 · Analytics › COA interpretation · 18 Mar 2026 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #7 · Evidence › Trials · 12 Mar 2026 · 0 likes An honest declaration on Subgroup analyses: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
Storing lyophilised material long term: what governs the shelf life Replied, post #90 · Practice › Storage & stability · 4 Mar 2026 · 1 like Noted, and thank you for writing it out rather than summarising it.
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #25 · Practice › Administration · 25 Feb 2026 · 16 likes On post #24 — agreed on the reasoning, with one qualification. The documentation on Rotating between abdomen is better than this thread and I say that as someone who…
-
A plateau that disappeared when I changed how I measured Replied, post #17 · Outcomes › Progress reports · 20 Feb 2026 · 0 likes A single scale used throughout beats a more accurate scale introduced halfway through. Consistency beats accuracy for a trend. Somebody will have a better source than…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #122 · Analytics › COA interpretation · 31 Jan 2026 · 31 likes Bookmarking this. I will come back when I have something worth adding.
-
Dead volume across syringe and needle combinations Replied, post #60 · Devices › Syringes & needles · 24 Jan 2026 · 0 likes If your calculated volume is under two graduations, choose a lower concentration rather than trying to read between marks. Precision comes from the preparation, not the…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #17 · Evidence › Trials · 23 Jan 2026 · 18 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
-
Request: a diff view for wiki revisions — the long version Replied, post #102 · Meta › Feature requests · 20 Jan 2026 · 8 likes Deprecation requests: if you think a feature should be removed or changed, that is also a request. Explain why you think it would improve the site.
-
Research-use-only labelling: what it means and what it does not Replied, post #87 · Sourcing › Regulatory · 14 Jan 2026 · 11 likes I have three months of notes on research-use-only labelling and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #35 · Regional › UK & Ireland · 3 Jan 2026 · 32 likes This follows post #32 rather than contradicting it. What I would tell a new member reading about Private prescribing for the first time: the confident posts are not the…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #16 · Compounds › Tirzepatide · 3 Jan 2026 · 7 likes The 2.5 mg starting dose is a tolerance step and not a therapeutic one. Judging efficacy at that dose is the single commonest reasoning error in this subcategory.
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #47 · Access › Pricing · 27 Dec 2025 · 0 likes Thank you — that answers what I came here to find out.
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #33 · Practice › Side effects · 27 Dec 2025 · 3 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Constipation management, with a dietitian's contribution Replied, post #13 · Practice › Side effects · 26 Dec 2025 · 12 likes On post #9 — agreed on the reasoning, with one qualification. Reframing constipation management slightly, because I think the disagreement is about the question rather…
-
Specification in the result column: why that is a meaningful error Replied, post #92 · Analytics › COA interpretation · 21 Dec 2025 · 15 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #70 · Compounds › Semaglutide · 16 Dec 2025 · 5 likes I would be cautious about generalising from the semaglutide half-life example above. It is a good example. It is one example.
-
Request: a diff view for wiki revisions — the long version Replied, post #84 · Meta › Feature requests · 14 Dec 2025 · 22 likes I would use that constantly. The objection is presumably that it is data the site then has to hold and protect for no benefit to anyone else. The general case is well…
-
Pricing far outside the range, in either direction Replied, post #7 · Sourcing › Red flags · 1 Dec 2025 · 28 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Robustness: the parameters worth deliberately varying Replied, post #31 · Analytics › Method validation · 30 Nov 2025 · 16 likes Building on post #28 rather than restating it. If you are new and reading this thread for the answer to robustness: the answer is conditional, the conditions are in the…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #94 · Practice › Reconstitution · 26 Nov 2025 · 9 likes Post #90 and I disagree about the size of the effect, not about the direction. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #58 · Compounds › Other compounds · 24 Nov 2025 · 13 likes Two sentences on Sequence verification and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What…
-
[2026 update] What steady state means for the decision to escalate Replied, post #46 · Practice › Dosing & titration · 9 Nov 2025 · 0 likes Taking post #45 at face value and following it one step further. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add…
-
Angle of injection and whether 90 degrees is always right Replied, post #46 · Practice › Administration · 6 Nov 2025 · 22 likes The claim about angle of injection upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
-
How to ask about something you suspect is a bad idea Replied, post #21 · Start Here › How to Ask · 1 Nov 2025 · 28 likes That matches what I have seen, for whatever a single anecdote is worth.
-
New subcategory: rationale and scope Replied, post #139 · Meta › Announcements · 27 Oct 2025 · 11 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #22 · Start Here › How to Ask · 24 Oct 2025 · 15 likes Post #21 is the version of this I will quote in future. One addition. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #4 · Start Here › Welcome · 16 Oct 2025 · 9 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #41 · Compounds › Cagrilintide & amylin analogues · 2 Oct 2025 · 6 likes The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The pharmacokinetics are the reason the dosing schedule makes sense.
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #19 · Analytics › Home & field testing · 27 Sep 2025 · 0 likes On post #16 — agreed on the reasoning, with one qualification. Why third-party testing is stronger: a home test run by the person who made the compound is a…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #3 · Start Here › Welcome · 26 Sep 2025 · 3 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #35 · Compounds › Other compounds · 3 Sep 2025 · 8 likes One more thing on catalogue breadth that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the…
-
A preprint whose numbers changed substantially at publication Replied, post #30 · Evidence › Preprints · 25 Aug 2025 · 0 likes Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion.
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #4 · Compounds › Tirzepatide · 23 Aug 2025 · 32 likes Bookmarking this. I will come back when I have something worth adding.
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #6 · Practice › Side effects · 20 Aug 2025 · 14 likes Picking up post #3: that is the part I would want checked first. My understanding of nausea timeline is a few years old and may have been superseded. If it has been, I…
-
[2026 update] Comparing documentation quality across the directory, tabulated Replied, post #4 · Sourcing › Vendor reports · 19 Aug 2025 · 0 likes Where you have no independent result, a documentation report is still worth filing: what the certificate contained, what it omitted, and how fast a request was answered.
-
How this community escalates rather than diagnoses Replied, post #2 · Safety › Adverse events · 11 Aug 2025 · 33 likes An event that is severe, unexpected or persistent should be assessed rather than reasoned about. The asymmetry between the cost of being checked and the cost of being…
-
Trial registration and comparing the protocol with the paper Replied, post #25 · Evidence › Trials · 28 Jul 2025 · 3 likes Post #23 put the caveat in the right place and I want to underline it. Trial registration: I have looked for the primary source twice and failed twice. Either it does…
-
What a documentation review can and cannot tell you Replied, post #50 · Sourcing › Independent verification · 27 Jul 2025 · 1 like Post #46 describes the usual case. This is about the unusual one. Repeat testing: if you want to verify the same lot a second time, testing with a different service…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #51 · Data & Tools › Calculators · 14 Jul 2025 · 0 likes The most common input error is entering the vial mass in the concentration field. It produces a plausible number, which is why it survives.
-
Tracking that stops updating and then resumes Replied, post #4 · Sourcing › Logistics · 17 Jun 2025 · 0 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one. This is the sort of thing the wiki should carry and…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #136 · Access › Insurance & coverage · 16 Jun 2025 · 12 likes I read post #132 twice before replying, because I had assumed the opposite. Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction…
-
Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA Replied, post #3 · Compounds › Tirzepatide · 16 Jun 2025 · 0 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #24 · Data & Tools › Calculators · 13 Jun 2025 · 1 like I would put moderate confidence on the mainstream reading of titration planner refuses and no more. That is not scepticism for its own sake; it is where the sourcing…
-
A well-designed study with a badly written abstract Replied, post #125 · Evidence › Study critique · 2 Jun 2025 · 28 likes Taking well-designed study seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #40 · Evidence › Journal club · 28 May 2025 · 0 likes This follows post #39 rather than contradicting it. Small methodological point on SURMOUNT-4 and continuation versus withdrawal: repeating a measurement is cheap and…
-
Coming back to: Getting a referral rather than a refusal Replied, post #9 · Clinical › Prescriber conversations · 28 May 2025 · 26 likes For anyone finding this later: the short answer on Getting a referral is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #96 · Clinical › Comorbidities · 27 May 2025 · 0 likes Adding a reference point for obstructive sleep apnoea. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #121 · Sourcing › Independent verification · 19 May 2025 · 9 likes Adding the measurement that post #120 says would settle it. Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a…
-
Documenting an adverse event properly — the long version Replied, post #4 · Safety › Adverse events · 19 May 2025 · 0 likes Post #2 describes the usual case. This is about the unusual one. Pancreatitis is a genuine serious adverse event to know: severe epigastric pain, back pain, elevated…
-
Follow-up: Documentation that appears only after payment Replied, post #79 · Sourcing › Red flags · 15 May 2025 · 0 likes No notes. Posting so the count is not one.
-
Counter-ion content and its effect on measured mass Replied, post #38 · Analytics › Mass spectrometry · 13 May 2025 · 31 likes The arithmetic in post #35 is right; the assumption feeding it is the part to check. Resolution and mass accuracy are different specifications. An instrument can…
-
Adjudicated events and why the definition matters — the long version Replied, post #139 · Evidence › Trials · 6 May 2025 · 0 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #110 · Evidence › Journal club · 5 May 2025 · 10 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. The…
-
Scheduled maintenance and what will be unavailable Replied, post #121 · Meta › Announcements · 24 Apr 2025 · 22 likes Taking post #118 at face value and following it one step further. Adding what did not work for me on scheduled maintenance, since the failures never get written up and…
-
Revisiting: German, French and Dutch differences, compared Replied, post #14 · Regional › European Union · 22 Apr 2025 · 30 likes Germany: BfArM implements EU framework. Statutory insurance (the majority) excludes "lifestyle medicines" including weight management. Private prescription is common.…
-
Carryover and the ghost peak from last week's standard Replied, post #89 · Analytics › HPLC & UHPLC · 12 Apr 2025 · 33 likes What I can speak to on carryover is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Follow-up: What other technical communities get right that we do not Replied, post #59 · Lounge › Off topic · 5 Apr 2025 · 15 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
-
Telehealth prescribing models in the US Replied, post #79 · Regional › North America · 3 Apr 2025 · 15 likes United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated. Compounds are prescription-only. Coverage is decided by individual plans,…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #25 · Compounds › Secretagogues & GH axis · 15 Mar 2025 · 0 likes If someone has run Tesamorelin properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #44 · Practice › Reconstitution · 14 Mar 2025 · 0 likes Post #43 is right about the mechanism and I think understates the practical bit. Preservative effectiveness is tested against a defined microbial challenge under…
-
The topic list is dense — is that deliberate? Replied, post #90 · Meta › Site feedback · 29 Jan 2025 · 0 likes A methods point on topic list rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #45 · Compounds › Secretagogues & GH axis · 22 Jan 2025 · 23 likes I came in to disagree and I am leaving without a disagreement.
-
Follow-up: Individual participant data versus aggregate data Replied, post #95 · Evidence › Meta-analyses · 11 Jan 2025 · 0 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random. Filing this under…
-
A supplier that answers analytical questions with restated claims Replied, post #8 · Sourcing › Red flags · 9 Jan 2025 · 11 likes Answering the question post #4 raises rather than the one it answers. The guidelines draw that line for a practical reason as much as a fair one: reports accumulate…
-
Titrating on tolerability rather than on the calendar — the long version Replied, post #2 · Practice › Dosing & titration · 6 Jan 2025 · 0 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #56 · Compounds › Semaglutide · 29 Dec 2024 · 0 likes I changed my mind about Semaglutide formulation after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
-
When to suspect the method rather than the sample Replied, post #53 · Analytics › Method validation · 20 Dec 2024 · 13 likes Robustness testing deliberately varies the parameters most likely to drift — organic percentage, pH, temperature, flow — and shows the result does not. It is the part…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #18 · Compounds › Semaglutide · 19 Dec 2024 · 1 like On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Second pass at: A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #3 · Devices › Pens & autoinjectors · 16 Dec 2024 · 0 likes The opening post and I disagree about the size of the effect, not about the direction. Storage after first use: most pens can be stored at room temperature after first…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #47 · Access › Insurance & coverage · 29 Nov 2024 · 13 likes Step therapy requirements has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Promotion criteria, and the one that stops most nominations Replied, post #126 · Documentation › Doc review · 29 Nov 2024 · 4 likes An observation about promotion criteria that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
-
EMA product information as a primary source — does this still hold? Replied, post #50 · Regional › European Union · 16 Nov 2024 · 19 likes Adding the measurement that post #49 says would settle it. The documentation on EMA product information is better than this thread and I say that as someone who has…
-
When "no data" is the complete and final answer Replied, post #11 · Compounds › Other compounds · 29 Oct 2024 · 15 likes The honest summary for most of this subcategory: a plausible mechanism, animal data, and first-hand accounts. Saying so is more useful than assembling the accounts into…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #61 · Compounds › Other compounds · 20 Oct 2024 · 2 likes Melanotan II is a non-selective melanocortin agonist, which is why its effects are not confined to pigmentation. The non-selectivity is the mechanism and not a side…
-
Requesting a page: what makes a good request — what changed since Replied, post #27 · Documentation › Wiki requests · 10 Oct 2024 · 7 likes Objections to a request belong in the open, and a request that survives an objection is a stronger page for it.
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #66 · Practice › Administration · 29 Sep 2024 · 1 like Site reactions that appear immediately and settle within a day are described commonly here. Ones that appear a day later and spread are a different observation and…
-
Meeting a protein target on a suppressed appetite — one year on Replied, post #13 · Nutrition & Training › Protein & intake · 15 Sep 2024 · 15 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
-
Progressive overload when the scale is falling — one year on Replied, post #49 · Nutrition & Training › Resistance training · 12 Sep 2024 · 0 likes Strength and hypertrophy respond to different things, and preserving one during a deficit is a different objective from building the other.
-
Chronic kidney disease and the FLOW result Replied, post #31 · Clinical › Comorbidities · 20 Aug 2024 · 25 likes Reading back through the chronic kidney disease threads from last year, the same three questions come up every time and only one of them has ever been answered…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #77 · Evidence › Journal club · 28 Jul 2024 · 0 likes Coming back to post #76, because the follow-up matters more than the original answer. I would put moderate confidence on the mainstream reading of LEADER and no more.…
-
Coming back to: Pricing far outside the range, in either direction Replied, post #7 · Sourcing › Red flags · 22 Jul 2024 · 19 likes Post #5 and I disagree about the size of the effect, not about the direction. Pricing far outside the range is a question about a distribution, not about a value, and…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #31 · Compounds › Retatrutide · 18 Jul 2024 · 15 likes A theoretical mass for retatrutide is not published in the peer-reviewed literature in a form worth quoting. A report should state the mass observed on the instrument…
-
Cold packs, phase-change material, and what survives ten days Replied, post #26 · Sourcing › Logistics · 19 Jun 2024 · 0 likes I think the cold packs question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
The mass-error checker and its intended scope Replied, post #42 · Data & Tools › Calculators · 11 Jun 2024 · 19 likes Mass-error checker has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.